Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57


Persistence of an Oncogenic Papillomavirus Genome Requires cis Elements from the Viral Transcriptional Enhancer.

Van Doorslaer K, Chen D, Chapman S, Khan J, McBride AA.

MBio. 2017 Nov 21;8(6). pii: e01758-17. doi: 10.1128/mBio.01758-17.


CpG and UpA dinucleotides in both coding and non-coding regions of echovirus 7 inhibit replication initiation post-entry.

Fros JJ, Dietrich I, Alshaikhahmed K, Passchier TC, Evans DJ, Simmonds P.

Elife. 2017 Sep 29;6. pii: e29112. doi: 10.7554/eLife.29112.


Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.

Salabert AS, Vaysse L, Beaurain M, Alonso M, Arribarat G, Lotterie JA, Loubinoux I, Tafani M, Payoux P.

PLoS One. 2017 Sep 19;12(9):e0184630. doi: 10.1371/journal.pone.0184630. eCollection 2017.


Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.

Lopes A, Vanvarenberg K, Préat V, Vandermeulen G.

Mol Ther Nucleic Acids. 2017 Sep 15;8:404-415. doi: 10.1016/j.omtn.2017.07.011. Epub 2017 Jul 13.


Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

Hatefi A, Karjoo Z, Nomani A.

Biomacromolecules. 2017 Sep 11;18(9):2799-2807. doi: 10.1021/acs.biomac.7b00739. Epub 2017 Aug 24.


DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations.

Schnödt M, Schmeer M, Kracher B, Krüsemann C, Espinosa LE, Grünert A, Fuchsluger T, Rischmüller A, Schleef M, Büning H.

Mol Ther Nucleic Acids. 2016;5:e355. doi: 10.1038/mtna.2016.60.


Rational Development of A Polycistronic Plasmid with A CpG-Free Bacterial Backbone as A Potential Tool for Direct Reprogramming.

Dormiani K, Mir Mohammad Sadeghi H, Sadeghi-Aliabadi H, Forouzanfar M, Baharvand H, Ghaedi K, Nasr-Esfahani MH.

Cell J. 2017 Winter;18(4):565-581. Epub 2016 Sep 26.


Novel recombinant papillomavirus genomes expressing selectable genes.

Van Doorslaer K, Porter S, McKinney C, Stepp WH, McBride AA.

Sci Rep. 2016 Nov 28;6:37782. doi: 10.1038/srep37782.


Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Alton EW, Beekman JM, Boyd AC, Brand J, Carlon MS, Connolly MM, Chan M, Conlon S, Davidson HE, Davies JC, Davies LA, Dekkers JF, Doherty A, Gea-Sorli S, Gill DR, Griesenbach U, Hasegawa M, Higgins TE, Hironaka T, Hyndman L, McLachlan G, Inoue M, Hyde SC, Innes JA, Maher TM, Moran C, Meng C, Paul-Smith MC, Pringle IA, Pytel KM, Rodriguez-Martinez A, Schmidt AC, Stevenson BJ, Sumner-Jones SG, Toshner R, Tsugumine S, Wasowicz MW, Zhu J.

Thorax. 2017 Feb;72(2):137-147. doi: 10.1136/thoraxjnl-2016-208406. Epub 2016 Nov 16.


Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Kim N, Duncan GA, Hanes J, Suk JS.

J Control Release. 2016 Oct 28;240:465-488. doi: 10.1016/j.jconrel.2016.05.031. Epub 2016 May 16. Review.


New and emerging targeted therapies for cystic fibrosis.

Quon BS, Rowe SM.

BMJ. 2016 Mar 30;352:i859. doi: 10.1136/bmj.i859. Review.


Minicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer.

Munye MM, Tagalakis AD, Barnes JL, Brown RE, McAnulty RJ, Howe SJ, Hart SL.

Sci Rep. 2016 Mar 15;6:23125. doi: 10.1038/srep23125.


Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.

Hanoun N, Gayral M, Pointreau A, Buscail L, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):184-92. doi: 10.1089/hum.2015.151.


piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

Loperfido M, Jarmin S, Dastidar S, Di Matteo M, Perini I, Moore M, Nair N, Samara-Kuko E, Athanasopoulos T, Tedesco FS, Dickson G, Sampaolesi M, VandenDriessche T, Chuah MK.

Nucleic Acids Res. 2016 Jan 29;44(2):744-60. doi: 10.1093/nar/gkv1464. Epub 2015 Dec 17.


A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.

Alton EW, Boyd AC, Porteous DJ, Davies G, Davies JC, Griesenbach U, Higgins TE, Gill DR, Hyde SC, Innes JA; UK Cystic Fibrosis Gene Therapy Consortium *.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1389-92. doi: 10.1164/rccm.201506-1193LE. No abstract available.


Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.

Sum CH, Nafissi N, Slavcev RA, Wettig S.

PLoS One. 2015 Nov 12;10(11):e0142875. doi: 10.1371/journal.pone.0142875. eCollection 2015.


Evaluation of New Fluorescent Lipophosphoramidates for Gene Transfer and Biodistribution Studies after Systemic Administration.

Belmadi N, Berchel M, Denis C, Berthe W, Sibiril Y, Le Gall T, Haelters JP, Jaffres PA, Montier T.

Int J Mol Sci. 2015 Nov 2;16(11):26055-76. doi: 10.3390/ijms161125941.


Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Zulliger R, Conley SM, Naash MI.

J Control Release. 2015 Dec 10;219:471-487. doi: 10.1016/j.jconrel.2015.10.007. Epub 2015 Oct 9. Review.


Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.

Williams JA.

Vaccines (Basel). 2013 Jun 25;1(3):225-49. doi: 10.3390/vaccines1030225. Review.

Supplemental Content

Support Center